Microviable Therapeutics will be presenting at I Asturias International Meeting on Clinical Microbiology and Infectious Disease (AIMID 2022) on September 22-23. Claudio Hidalgo, CEO at Microviable, will discuss the use of “Microbiome-derived biotherapeutic products for infectious diseases”

The Microviable team will join other institutions and companies sharing about compelling issues and new trends in clinical microbiology and infectious diseases.

For more information or to meet with us at the conference please contact us